Investigators from the Cancer Research Center would like to better understand the opinions of patients and/or their loved ones about the use of medical cannabis.
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
A video update from Kenzi Riboulet-Zemouli and Michael Krawitz on the World Health Organization’s recommendations on cannabis scheduling and international cannabis law.
A team of cannabis researchers is investigating the use of cannabis containing the cannabinoid cannabigerol (CBG) and people’s experiences with it.
Authors: Sharon R Sznitman, Simon Vulfsons, David Meiri, Galit Weinstein Published in Drug and Alcohol Review September 2020 Abstract Introduction and aims: Cannabis exposure is becoming more common in older age but little is known about how it is associated with brain health in this population. This study assesses the relationship between long-term medical cannabis…
By Matt Cascio, RN, CCFP, Compassion Fatigue Coach I’ve been a Registered Nurse (RN) for 22 years. My practice is more holistic these days, rather than in a hospital setting. At 38 years old, I became a RN after a complete career change. In 2016, I decided to accept a job in an Infusion Center…
This is a statement delivered by Dr. Joel Wren from the Society of Cannabis Clinicians regarding the follow-up discussions on the recommendations of the World Health Organization on cannabis and cannabis-related substances on October 8th, 2020.
Answers from SCC Members to an inquiry on the safety of using CBD when patients are taking medications metabolized by the P450 system.
A webinar focused on sharing best practices from primary care physicians. The session explores the applications of medical cannabis for chronic pain, fibromyalgia, mood disorders, reducing opioid dependence and benzodiazepines, and more.
SCC Member Gretchen E. Maurer, DO, MS and colleagues examine the current research potential for cannabis in sports medicine.
El evento inaugural del Capítulo Colombia/Latinoamérica de la Society of Cannabis Clinicians con la participación de investigadores Latinoamericanos. Grabado el viernes 18 de Septiembre 2020.
Survey data reported that less than 20% of patients believe that their primary care providers are knowledgeable about cannabis-specific medical issues.
Ziva Cooper, PhD presents “Controlled Human Laboratory Studies of Cannabis and Cannabinoids: Probing Current Trends in Medicinal Cannabis” at the SCC Quarterly Meeting. Dr. Cooper discusses research examining the differences between men and women in their response to the pain-relieving effects of cannabis, the potential for cannabis to reduce reliance on opioids, and therapeutic effects of cannabinoids in patient populations.